CoChat

Airflow Limitation Increases Lung Cancer Risk in Smokers: The Lifelines Cohort Study

Du, Yihui, Sidorenkov, Grigory, Groen, Harry J.M., Heuvelmans, Marjolein A., Vliegenthart, Rozemarijn, Dorrius, Monique D., Timens, Wim, de Bock, Geertruida H. · 2022 · Cancer Epidemiology, Biomarkers & Prevention

Published version of a preprint

Cited by 9

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: The relationship between smoking, airflow limitation, and lung cancer occurrence is unclear. This study aims to evaluate the relationship between airflow limitation and lung cancer, and the effect modification by smoking status. Methods: We included participants with spirometry data from Lifelines, a population-based cohort study from the Northern Netherlands. Airflow limitation was defined as FEV1/FVC ratio < 0.7. The presence of pathology-confirmed primary lung cancer during a median follow-up of 9.5 years was collected. The Cox regression model was used and hazard ratios (HR) with 95% confidence interval (95% CI) were reported. Adjusted confounders included age, sex, educational level, smoking, passive smoking, asthma status and asbestos exposure. The effect modification by smoking status was investigated by estimating the relative excess risk due to interaction (RERI) and the ratio of HRs with 95% CI. Results: Out of 98,630 participants, 14,200 (14.4%) had airflow limitation. In participants with and without airflow limitation, lung cancer incidence was 0.8% and 0.2%, respectively. The adjusted HR between airflow limitation and lung cancer risk was 1.7 (1.4–2.3). The association between airflow limitation and lung cancer differed by smoking status [former smokers: 2.1 (1.4–3.2), current smokers: 2.2 (1.5–3.2)] and never smokers [0.9 (0.4–2.1)]. The RERI and ratio of HRs was 2.1 (0.7–3.4) and 2.5 (1.0–6.5) for former smokers, and 4.6 (95% CI, 1.8–7.4) and 2.5 (95% CI, 1.0–6.3) for current smokers, respectively. Conclusions: Airflow limitation increases lung cancer risk and this association is modified by smoking status. Impact: Ever smokers with airflow limitation are an important target group for the prevention of lung cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-21-1365

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 31

  1. Parris, 2019, Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis, J Thorac Dis, 11, S2155, 10.21037/jtd.2019.10.54 · DOI · Paper page
  2. De Torres, 2007, Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest, Chest, 132, 1932, 10.1378/chest.07-1490 · DOI · Paper page
  3. Wilson, 2008, Association of radiographic emphysema and airflow obstruction with lung cancer, Am J Respir Crit Care Med, 178, 738, 10.1164/rccm.200803-435OC · DOI · Paper page
  4. Purdue, 2007, Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers, Thorax, 62, 51, 10.1136/thx.2006.064196 · DOI
  5. de Torres, 2011, Lung cancer in patients with chronic obstructive pulmonary disease incidence and predicting factors, Am J Respir Crit Care Med, 184, 913, 10.1164/rccm.201103-0430OC · DOI · Paper page
  6. Powell, 2013, Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis, J Thorac Oncol, 8, 6, 10.1097/JTO.0b013e318274a7dc · DOI
  7. Powell, 2013, Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis, J Thorac Oncol, 8, e34, 10.1097/JTO.0b013e31828950e3 · DOI
  8. Molins, 2013, Chronic obstructive pulmonary disease and risk of lung cancer: The importance of smoking and timing of diagnosis, J Thorac Oncol, 8, e34, 10.1097/JTO.0b013e318286c1c1 · doi:10.1097/jto.0b013e318286c1c1
  9. Durham, 2015, The relationship between COPD and lung cancer, 121
  10. Park, 2020, Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study, Thorax, 75, 506, 10.1136/thoraxjnl-2019-213732 · doi:10.1136/thoraxjnl-2019-213732
  11. Young, 2021, Incorporating baseline lung function in lung cancer screening: Does a “lung health check” help predict outcomes?, Chest, 159, 1664, 10.1016/j.chest.2020.10.070 · doi:10.1016/j.chest.2020.10.070
  12. Balata, 2020, Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD, Thorax, 75, 655, 10.1136/thoraxjnl-2019-213584 · DOI
  13. Hill, 2010, Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care, CMAJ, 182, 673, 10.1503/cmaj.091784 · DOI · Paper page
  14. Klijs, 2015, Representativeness of the LifeLines Cohort Study, PLoS One, 10, e0137203, 10.1371/journal.pone.0137203 · DOI · Paper page
  15. Miller, 2005, Standardisation of spirometry, Eur Respir J, 26, 319, 10.1183/09031936.05.00034805 · DOI · Paper page
  16. Quanjer, 2012, Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations, Eur Respir J, 40, 1324, 10.1183/09031936.00080312 · DOI · Paper page
  17. Vogelmeier, 2017, Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary, Am J Respir Crit Care Med, 195, 557, 10.1164/rccm.201701-0218PP · DOI · Paper page
  18. Faruque, 2021, Airborne occupational exposures and inflammatory biomarkers in the Lifelines cohort study, Occup Env Med, 78, 82, 10.1136/oemed-2020-106493 · DOI
  19. Uribe, International Job Exposure Matrix for Asbestos-IJEMA
  20. Thiébaut, 2004, Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study, Stat Med, 23, 3803, 10.1002/sim.2098 · DOI · Paper page
  21. Hopkins, 2017, Reduced expiratory flow rate among heavy smokers increases lung cancer risk: Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort, Ann Am Thorac Soc, 14, 392, 10.1513/AnnalsATS.201609-741OC · DOI
  22. Smith, 2020, Association of dysanapsis with chronic obstructive pulmonary disease among older adults, JAMA, 323, 2268, 10.1001/jama.2020.6918 · DOI · Paper page
  23. Thomsen, 2013, Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study, Lancet Respir Med, 1, 543, 10.1016/S2213-2600(13)70137-1 · DOI
  24. Denholm, 2014, Is previous respiratory disease a risk factor for lung cancer?, Am J Respir Crit Care Med, 190, 549, 10.1164/rccm.201402-0338OC · DOI
  25. Muller, 2017, Lung cancer risk prediction model incorporating lung function: development and validation in the UK Biobank Prospective Cohort Study, J Clin Oncol, 35, 861, 10.1200/JCO.2016.69.2467 · DOI
  26. Warkentin, 2019, Determinants of impaired lung function and lung cancer prediction among never-smokers in the UK Biobank Cohort, EBioMedicine, 47, 58, 10.1016/j.ebiom.2019.08.058 · DOI
  27. Mark, 2018, Chronic obstructive pulmonary disease alters immune cell composition and immune checkpoint inhibitor efficacy in non-small cell lung cancer, Am J Respir Crit Care Med, 197, 325, 10.1164/rccm.201704-0795OC · DOI
  28. Papi, 2004, COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma, Thorax, 59, 679, 10.1136/thx.2003.018291 · DOI · Paper page
  29. Young, 2010, Lung function predicts lung cancer, Eur Respir J, 35, 1421, 10.1183/09031936.00009410 · doi:10.1183/09031936.00009410
  30. Nagasaka, 2020, COPD and lung cancer incidence in the Women's Health Initiative Observational Study: a brief report, 78
  31. Swanney, 2008, Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction, Thorax, 63, 1046, 10.1136/thx.2008.098483 · DOI · Paper page

Metadata

Authors
Du, Y., Sidorenkov, G., Groen, H. J. M., Heuvelmans, M. A., Vliegenthart, R., Dorrius, M. D., Timens, W., & de Bock, G. H.
Venue
Cancer Epidemiology, Biomarkers & Prevention
Published
2022-05-09
Volume
31
Issue
7
Pages
1442-1449
ISSN
  • 1055-9965
  • 1538-7755
Cited by
9
References
5
Language
en
Funders
China Scholarship Council (201708340072)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Airflow Limitation Increases Lung Cancer Risk in Smokers: The Lifelines Cohort Study. https://app.cochat.ai/papers/10.1158/1055-9965.epi-21-1365
The paper
Du, Y., Sidorenkov, G., Groen, H. J. M., Heuvelmans, M. A., Vliegenthart, R., Dorrius, M. D., Timens, W., & de Bock, G. H. (2022). Airflow Limitation Increases Lung Cancer Risk in Smokers: The Lifelines Cohort Study. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-21-1365

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.